-+ 0.00%
-+ 0.00%
-+ 0.00%

Raymond James Initiates Coverage On Vir Biotechnology with Outperform Rating, Announces Price Target of $12

Benzinga·07/11/2025 13:04:32
Listen to the news
Raymond James analyst Sean McCutcheon initiates coverage on Vir Biotechnology (NASDAQ:VIR) with a Outperform rating and announces Price Target of $12.